Regulatory agencies within the United States and the United Kingdom have reviewed extensively the safety and efficacy of Halcion (triazolam) - a once commonly used hypnotic drug. This book assesses the adequacy of the drug's clinical trials, the quality and quantity of data on adverse reactions, and overall confidence in the data on effectiveness.